Skip to Main Content

Paper Details

Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.
Cancer Cell
74
2019
CSF2RB, Cas9, Children, DS, Down Syndrome, Down syndrome, GATA1, ML-DS, ML-DS genes, Myeloid Preleukemia, Myeloid leukemia, TAM, TAM variants, Transformed Myeloid Leukemia, leukemias, murine, myeloid cytokine receptor CSF2RB, preleukemic, transient abnormal myelopoiesis, trisomy 21
Author NameAffiliation
S??ren MatzkMartin-Luther-University Halle-Wittenberg, Germany Max Planck Institute for Molecular Genetics
Vyacheslav AmstislavskiyMax Planck Institute for Molecular Genetics
Thomas RischMax Planck Institute for Molecular Genetics
Udo OppermannBotnar Research Centre, Oxford NIHR BRC and Structural Genomics Consortium, UK University of Oxford
Mitchell J WeissSt. Jude Children's Research Hospital
Seishi OgawaGraduate School of Medicine, Kyoto University, Kyoto Japan Center for Hematology and Regenerative Medicine, Karolinska Institute
Marie-Laure YaspoMax Planck Institute for Molecular Genetics
Peter J CampbellWellcome Trust Sanger Institute
  • 1 - 8

Datasets

Release 1.2